JeffreyN.MyersMD

PubMed

• 2 citations
  Oral Pre-malignancy: An Update on Novel Therapeutic Approaches.
  Shorook Naara, Clara Andrews, Andrew Sikora, Michelle Williams, Mark Chambers
  Current Oncology Reports. 2024-09-01
• 1 citations
  Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral cancer.
  Chieko Michikawa, Frederico O Gleber-Netto, Curtis R Pickering, Xiayu Rao, Jing Wang
  Oral Oncology. 2024-06-01
• Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6-Year Prospective Registry Analysis.
  Brady J Anderson, Amy C Moreno, Yun Qing, J Jack Lee, Faye M Johnson
  Otolaryngology--Head and Neck Surgery. 2024-05-01

Journal Articles

• PI3‐Kinase Pathway Biomarkers in Oral Cancer and Tumor Immune Cells  
  Bonnie S Glisson, Jeffrey Myers, N Jr William, Renata Ferrarotto, Head & Neck
• Outcomes of Microvascular Flap Reconstruction of the Head and Neck in Patients Receiving Systemic Immunosuppressive Therapy for Organ Transplantation  
  Peirong Yu, Jeffrey N Myers, Journal of Surgical Oncology
•  
  Lam-Ubol A, Fitzgerald AL, Ritdej A, Phonyiam T, Zhang H, Myers JN, Huang P, Trachootham D, Royal Society of Chemistry - Food and Function, 1/1/2018
• Targeting the DNA Damage Response in OSCC with TP53 Mutations  
  Lindemann A, Takahashi H, Patel AA, Osman AA, Myers JN, J Dent Res, 1/1/2018
• Combat Readiness, Harm Aversion, and Promotion Eligibility: A Qualitative Study of US Servicemembers Views on Tobacco Use and Control in the Military  
  Singaraju RC, Myers JN, Owczarzak JT, Gielen AC, Mil Med, 1/1/2018
• Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma  
  Ma J, Fu Y, Tu YY, Liu Y, Tan YR, Ju WT, Pickering CR, Myers JN, Zhang ZY, Zhong LP, BMC Cancer, 1/1/2018
• CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition  
  Gadhikar MA, Zhang J, Shen L, Rao X, Wang J, Zhao M, Kalu NN, Johnson FM, Byers LA, Heymach J, Hittelman WN, Udayakumar D, Pandita RK, Pandita TK, Pickering CR, Redwoo..., Cancer Res, 1/1/2018
• Risk Stratification of Oral Potentially Malignant Disorders in Fanconi Anemia Patients Using Autofluorescence Imaging and Cytology-On-A Chip Assay  
  Abram TJ, Pickering CR, Lang AK, Bass NE, Raja R, Meena C, Alousi AM, Myers JN, McDevitt JT, Gillenwater AM, Vigneswaran N, Transl Oncol, 1/1/2018
• High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma  
  Sandulache VC, Michikawa C, Kataria P, Gleber-Netto FO, Bell D, Trivedi S, Rao X, Wang J, Zhao M, Jasser S, Myers JN, Pickering CR, Clin Cancer Res, 1/1/2018
• Multimodality Analysis Supports APOBEC as a Major Source of Mutations in Head and Neck Squamous Cell Carcinoma  
  Faden DL, Thomas S, Cantalupo PG, Agrawal N, Myers J, DeRisi J, Oral Oncology, 1/1/2017
• PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions  
  Wang J, Xie T, Wang B, William WN, Heymach JV, El-Naggar AK, Myers JN, Caulin C, Cancer Prev Res (Phila), 1/1/2017
• Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma  
  Schvartsman G, Perez K, Flynn JE, Myers JN, Tawbi H, Journal for ImmunoTherapy of Cancer, 1/1/2017
• Impact of Cardiorespiratory Fitness on Mortality in Black Male Veterans With Resistant Systemic Hypertension  
  Narayan P, Doumas M, Kumar A, Faselis CJ, Myers JN, Pittaras A, Kokkinos PF, Am J Cardiol, 1/1/2017
• Replication stress leading to apoptosis within the S-phase contributes to synergism between vorinostat and AZD1775 in HNSCC harboring high risk TP53 mutation  
  Tanaka N, Patel AA, Tang L, Silver NL, Lindemann A, Takahashi H, Jaksik R, Rao X, Kalu NN, Chen TC, Wang J, Frederick MJ, Johnson F, Gleber-Netto FO, Fu S, Kimmel M, W..., Clin Cancer Res, 1/1/2017
• APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism  
  Chen TW, Lee CC, Liu H, Wu CS, Pickering CR, Huang PJ, Wang J, Chang IY, Yeh YM, Chen CD, Li HP, Luo JD, Tan BC, Chan TEH, Hsueh C, Chu LJ, Chen YT, Zhang B, Yang CY, ..., Nat Commun, 1/1/2017
• Sudden hearing loss in a melanoma patient on pembrolizumab: An Etiology not to be omitted in the differential diagnosis  
  Nader ME, Myers JN, Gidley PW, J Immunother Cancer, 1/1/2017
• Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates  
  Chitsazzadeh V, Coarfa C, Drummond JA, Nguyen T, Joseph A, Chilukuri S, Charpiot E, Adelmann CH, Ching G, Nguyen TN, Nicholas C, Thomas VD, Migden M, MacFarlane D, Tho..., Nat Commun, 1/1/2016
• JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma  
  Hyakusoku H, Sano D, Takahashi H, Hatano T, Isono Y, Shimada S, Ito Y, Myers JN, Oridate N, J Exp Clin Cancer Res, 1/1/2016
• Enhanced Radiosensitization of Gold Nanospikes via Hyperthermia in Combined Cancer Radiation and Photothermal Therapy  
  Ma N, Jiang YW, Zhang X, Wu H, Myers JN, Liu P, Jin H, Gu N, He N, Wu FG, Chen Z, ACS Appl Mater Interfaces, 1/1/2016
• Wee-1 kinase inhibition sensitizes high risk HPV+ HNSCC to apoptosis accompanied by downregulation of MCl-1 and XIAP antiapoptotic proteins  
  Tanaka N, Patel AA, Wang J, Frederick MJ, Kalu NN, Zhao M, Fitzgerald AL, Xie TX, Silver NL, Caulin C, Zhou G, Skinner HD, Johnson FM, Myers JN, Osman AA, Clin Cancer Res, 1/1/2015
• Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer  
  Neskey DM, Osman AA, Ow TJ, Katsonis P, McDonald T, Hicks SC, Hsu TK, Pickering CR, Ward A, Patel A, Yordy JS, Skinner HD, Giri U, Sano D, Story MD, Beadle BM, El-Nagg..., Cancer Res, 1/1/2015
• Evolutionary Action Score of TP53 Coding Variants (EAp53) is Predictive of Platinum Response in Head and Neck Cancer Patients  
  Osman AA, Neskey DM, Katsonis P, Patel AA, Ward AM, Hsu TK, Hicks SC, McDonald TO, Ow TJ, Alves MO, Pickering CR, Skinner HD, Zhao M, Sturgis EM, Kies MS, El-Naggar A,..., Cancer Res, 1/1/2015
• Wee-1 Kinase Inhibition Overcomes Cisplatin Resistance Associated with High Risk TP53 Mutations in Head and Neck Cancer through Mito tic Arrest Followed by Senescence  
  Osman AA, Monroe MM, Ortega Alves MV, Patel AA, Katsonis P, Fitzgerald AL, Neskey DM, Frederick MJ, Woo SH, Caulin C, Hsu TK, McDonald TO, Kimmel M, Meyn RE, Lichtarge..., Mol Cancer Ther, 1/1/2015
• Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma  
  Zhong LP, Zhang CP, Ren GX, Guo W, William WN, Hong CS, Sun J, Zhu HG, Tu WY, Li J, Cai YL, Yin QM, Wang LZ, Wang ZH, Hu YJ, Ji T, Yang WJ, Ye WM, Li J, He Y, Wang YA,..., Oncotarget, 1/1/2015
• Biobanking in Genomic Medicine  
  Zhou JH, Sahin AA, Myers JN, Arch Pathol Lab Med, 1/1/2015
• Join now to see all

Books/Book Chapters

• Molecular Determinants of Head and Neck Cancer. 
  Chapter: Sequencing HNC: Emergence of Notch Signaling. 
  Pickering CR, Ow TJ, Myers JNEditors: Burtness B, Golemis E.Springer Science+Business Media, New York, NY2014
• Cummings Otolaryngology: Head & Neck Surgery 
  Chapter: Chemotherapy and Targeted Biologic Agents for Head and Neck Squamous Cell Carcinoma. 
  Page 4557 - 4696Myers JN, Kies MEEditors: Flint & Haughey & Lund & Niparko & Richardson & Robbins & Thomas.Elsevier, Inc.Edition 6th,2014
• Targeted Therapy in Translational Cancer Research. 
  Chapter: Targeted Therapy in Head and Neck Squamous Cell Carcinoma. 
  Monroe MM, Myers JNEditors: Bast RC, Kurzrock R, Anderson KC.Wiley2014
• Bailey's Head and Neck Surgery: Otolaryngology. 
  Chapter: Malignant Melanoma of the Head and Neck Region. 
  Berger AJ, Myers JN, Nemechek AJ, Yao MEditors: Jonas JT, Rosen CA.Lippincott Williams & Wilkins, Boston, MA; Philadelphia, PAEdition 2nd,2013
• Master Techniques in Otolaryngology - Head and Neck Surgery: Head and Neck Surgery: Volume 2: Thyroid, Parathyroid, Salivary Glands, Paranasal Sinuses and Nasopharynx. 
  Chapter: Posterolateral Neck Dissection. 
  Page 67 - 72Myers JNEditors: Myers EN, Ferris RL.Lippincott Williams & Wilkins2013
• Head and Neck Cancer: Multimodality Management 
  Chapter: Head and Neck Melanoma. 
  Andrews G, Myers JNEditors: Jack Bernier.Springer Verlag, New York, NY2011
• Oral cancer metastasis. 
  Chapter: Animal Models of Oral Cancer Metastasis. 
  Page 135 - 162Milas Z, Myers JN, Caulin CSpringer, New York, NY2010
• Head and Neck Cancer : A Multidisciplinary Approach 
  Chapter: Angiogenesis and metastases in head and neck cancer. 
  Galer CE, MyersJNEditors: Harrison LB, Sessions RB, Hong WK.Lipppincott Williams & Wilkins, Philadelphia, PAEdition 3rd,2009
• Clinical Neurosurgery 
  Chapter: Primary sarcomas of the skull base: An analysis of 63 cases. 
  Prabhu SS, Diaz E, Sturgis EM, Myers JN, Suki D, DeMonte F2004
• Surgical Oncology Clinics of North America; Current Diagnosis and Therapy for Head and Neck Malignancies. 
  Chapter: Melanoma of the head and neck: Current concepts in staging, diagnosis, and management. 
  Younes MN, Myers JN2003
• Essentials of Otolaryngology and Neck Surgery 
  Chapter: Carcinoma of the oral cavity and pharynx. 
  Page 567 - 595Holsinger FC, Myers JNEditors: Lee.Edition 8th,2003
• Soft tissue sarcomas of the head and neck in soft tissue sarcomas. 
  Sturgis EM, Myers JNBC Decker, Inc.2002
• Decision-Making in ENT Disorders. 
  Chapter: Nasopharyngeal cancer. 
  Sturgis EM, Myers JNWB Saunders Company2001
• Metastases in Head and Neck Cancer 
  Chapter: Metastases of squamous cell carcinoma of the oral tongue. 
  Myers JN2001
• The role of sentinel lymph node mapping and biopsy in cutaneous melanomas of the head and neck region. 
  Myers JN2001
• Decision-Making in ENT Disorders. 
  Chapter: Malignant melanoma. 
  Nemechek AJ, Myers JNW. B. Saunders Co2001
• Head & Neck Surgery-Otolaryngology. 
  Chapter: Malignant melanoma. 
  Nemechek A, Myers JNLippincott Williams & Wilkins2001
• Cancer of the Head and Neck. 
  Chapter: Melanoma of the head and neck. 
  Lentsch EJ, Myers JNWB Saunders and Co2000
• Cancer of the Head and Neck 
  Chapter: Pathogenesis and progression of squamous cell carcinoma of the head and neck. 
  Lentsch EJ,Myers JN2000
• Melanoma. 
  Chapter: Melanoma of the head and neck region. 
  Lentsch EJ, Myers JNSpringer-Verlag2000
• Plastic Surgery Secrets. 
  Chapter: Head and neck cancer. 
  Page 175 - 185Callender DL, Myers JNHanley & Belfus, Inc.1999
• Current Therapy in Otolaryngology in Head and Neck Surgery. 
  Chapter: Carcinoma of the anterior tongue. 
  Myers JN, Myers ENMosby Year Book1998
• Cancer Da Laringe. 
  Chapter: Cirugia conservadora para o cancer glotico. 
  Myers JN, Myers ENRevinter1997
• Cancer of the Head and Neck. 
  Chapter: Immunotherapy of head and neck cancer. 
  Myers JN, Whiteside TLW.B. Saunders1996
• The Larynx: A Multidisciplinary Approach. 
  Chapter: Benign neoplasms of the larynx in fried MP. 
  Myers JN, Barnes LE, Myers ENMosby Year Book1996
• Join now to see all

Abstracts/Posters

• Immunohistochemical Expression of Hormone Receptors in Melanoma of Pregnant Women, Non-pregnant Women and Men: a Comparison Study.
  Zhou JH, Kim KB, Fox P, Myers JN, Prieto VG, United States and Canadian Academy of Pathology 102nd Annual Meeting, 1/1/2013
• MK-1775, A Selective wee1 Kinase Inhibitor, Overcomes Cisplatin Resistance Associated with High Risk TP53 Mutations in Squamous Cell Carcinoma of the Head and Neck.
  Osman AA, Alves MO, Neskey DM, Monroe MM, Patel AA, Chuang H, Mason L, Meyn RE, Byers LA, Katsonis P, Lichtarge O, Myers JN, American Association of Cancer Research Annual Meeting, 1/1/2013
• SOCS2 (Suppressor of Cytokine Signaling Protein 2) is a Prognostic Indicator of Progression-Free Survival in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients.
  Nicholas C, Nunez MI, Harun N, Lee JJ, Myers JN, Wistuba II, Sen B, El-Naggar AK, Lai SY, Johnson FM, William WN, American Association for Cancer Research, 1/1/2013
• Angiogenic Activity Leads Failure of Antitumor Activity of Cixutumumab, an Anti-Insulin Like Growth Factor Receptor Monoclonal Antibody.
  Lee J, Kang J, Boo H, Myers JN, Johnson FM, Glisson BS, Oh S, Lee H, American Association for Cancer Research, 1/1/2013
• Overcoming the Cisplatin Resistance of HNSCC Cells through Chk1/2 Inhibition.
  Gadhikar MA, Sciuto MR, Alves Ortega MV, Pickering CR, Monroe M, Osman AA, Neskey DM, Sturgis EM, Myers JN, Frederick MJ, American Association for Cancer Research, 1/1/2013
• Reactive Oxygen Species and p21Waf1/Cip1 are Essential for Radiation-Induced Accelerated Senescence of Head and Neck Cancer Cells.
  Fitzgerald AL, Osman AA, Neskey DM, Patel A, Skinner H, McDonnell T, Myers JN, American Association for Cancer Research, 1/1/2013
• Her2/neu as A New Therapeutic Target of Sinonasal Undifferentiated Carcinoma.
  Takahashi Y, Bell D, Hanna EY, Myers JN, Kupferman ME, 23rd Annual North American Skull Base Society Meeting, 1/1/2013
• IL-6 stimulates cell motility in squamous cell carcinoma of head and neck (SCCHN) cells through CK2 phosphorylation and stabilization of TWIST.
  Su Y-W, Xie T-X, Frederick MJ, Daisuke S, Myers JN, AACR Meeting, Washington, DC, 1/1/2010
• Treatment with vandetanib can overcome resistance of head and neck squamous cell carcinoma cells to cisplatin and radiation in an orthotopic animal model.
  Sano D, Matsumoto F, Valdecanas DR, Zhao M, Molkentine DP, Papadimitrakopoulou V, Heymach J, Raju U, Milas L, Myers JN, AACR Meeting, Washington, DC, 1/1/2010
• Gain of function of p53 mutations disrupt the ATM-mediated DNA damage response in HNSCC cell lines.
  Zhou G, Zhao M, Xie T, Jasser SA, Myers JN, Final Program and Abstract Book of the 7th International Conference on Head and Neck Cancer, 1/1/2008
• Reciprocal Negative Regulation Between S100A7/psoriasin and ss-Catenin Signaling in SCCOC Tumor Progression.
  Zhou G, Myers JN, Final Program and Abstract Book of the 7th International Conference on Head and Neck Cancer, 1/1/2008
• The effect of combined EGFR and VEGFR-2 targeted therapy, on orthotopic xenografts of SCCOT.
  Sano D, Choi S, Milas ZL, Zhou G, Zhao M, Su YW, Chad G, Maria G, Jasser SA, Myers JN, Final Program and Abstract Book of the 7th International Conference on Head and Neck Cancer, 1/1/2008
• Single-walled carbon nanotubes associated with paxlitaxel inhibit the growth of head and neck squamous cell tumors.
  Milas Z, Lucente-Schultz R, Sano D, Galer C, Gule M, Leonard AD, Price BK, Kosynkin D, Tour J, Myers JN, Final Program and Abstract Book of the 7th International Conference on Head and Neck Cancer, 1/1/2008
• ZD6474 causes significant inhibition of anaplastic thyroid cancer in an orthotopic murine model.
  Gule M, Sano D, Milas Z, Zaho M, Jasser SA, Myers JN, Final Program and Abstract Book of the 7th International Conference on Head and Neck Cancer, 1/1/2008
• Psoriasin/S100A7 Modulates b-catenin Signaling and Inhibits Tumor Growth and Progression of Oral Cavity Squamous Cell Carcinoma.
  Zhou G, Mandal M, Jasser SA, Zhao M, Yazici YD, Xie T, Younes MN, Kupferman ME, Patel V, Gutkind SJ, El-Naggar AK, Emberley ED, Watson PH, Bucana CD, Myers JN, 97th Annual American Association for Cancer Research Meeting, Los Angeles, CA, 1/1/2007
• In vivo Imaging of Primary Recurrence and Cervical Lymph Node Metastases in an Orothotopic Nude Mouse Model of Squamous Cell Carcinoma of the head and Neck.
  Younes MN, Zhou G, Jasser SA, Myers JN, Combined Otolaryngological Spring Meeting, San Diego, CA, 1/1/2007
• The prevalence of BRAFV599E mutation in anaplastic thyroid carcinoma.
  Kim S, Sreevidya CS, Ananthaswamy HN, El-Naggar AK, Jasser SA, Myers JN, 95th Annual Meeting of the American Association for Cancer Research, Orlando, FL, 1/1/2004
• Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease?
  Ballo MT, Zagars GK, Lee JE, Myers JN, Diaz EM, Sturgis EM, Gershenwald JE, Ross MI, Weber RS, 1/1/2003
• Dual inhibition of EGFR and VEGFR in squamous cell carcinoma of the head and neck: the role of the new EGFR/VEGFR inhibitor NVP-AEE788.
  Yigitbasi OG, Younes MN, Schiff, BA, Doan D, Jasser SA, Al-Muhtaseb Z, Myers JN, American Association for Cancer Research, Boston, MA, 1/1/2003
• The Effective of NVP AEE788 � A Dual Inhibitor of EGFR and VEGFR Tyrosine Kinase on Anaplastic Thyroid Carcinoma Growth.
  Kim S, Schiff BA, Doan DD, Younes MN, Jasser SA, Yigitbasi OG, et al, AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Boston, MA, 1/1/2003
• Selective neck dissection is sufficient for persistent neck disease after radiation therapy for advanced stage oropharynx squamous carcinoma.
  Simon C, Robert D, Rosenthal DI, Diaz EM, Goepfert H, Myers JN, Nashville, TN, 1/1/2003
• Integrin linked kinase (ILK) is overexpressed and ILK inhibition leads to growth inhibition of anaplastic thyroid cancer cells.
  Myers JN, Nashville, TN, 1/1/2003
• Inhibition of integrin linked kinase restores anoikis to squamous cell carcinoma of the head and neck cancer cells.
  Younes M, Swan EA, Doan DD, Myers JN, American Association for Cancer Research, Washington, DC, 1/1/2003
• An orthotopic nude mouse model of thyroid cancer.
  Schiff B, Jasser S, Doan D, Yeung S-C J, Myers JN, American Association for Cancer Research, Washington, DC, 1/1/2003
• PI3-K/AKT signaling in oral cancer progression.
  Myers JN, Washington, DC, 1/1/2002
• Join now to see all

Lectures

• Myers JN. Multi-Disciplinary Head & Neck Cancer Care in 2018 
  University of Arkansas for Medical Sciences, Little Rock, AR - 1/16/2018
• The Role of the Otolaryngologist - Head and Neck Surgeon in Oropharyngeal Cancer Management 
  University of Arkansas for Medical Sciences, Little Rock, AR - 1/16/2018
• Personalizing HNSCC treatment based on TP53 mutational status 
  San Diego, CA - 1/24/2017
• Molecular Biology of Head and Neck Cancer Detection 
  San Diego, CA - 1/22/2017
• Neoadjuvant and Surgical Approaches for HNSCC 
  University of Texas MD Anderson Cancer Center, Houston, TX - 1/21/2017
• Proteomic Profiling and Genomic Drivers of Oral Cancer 
  University of Texas MD Anderson Cancer Center, Houston, TX - 1/18/2017
• Biomarkers in Head and Neck Cancer 
  University of Michigan School of Dentistry, Ann Arbor, MI - 1/16/2017
• New Advances in Translational Research of Oral Cancer 
  Ohio State University Comprehensive Cancer Center, Columbus, OH - 1/5/2017
• Melanoma of the Head and Neck Region 
  Eilat, Israel - 1/3/2017
• Cancer of the Larynx 
  Eilat, Israel - 1/2/2017
• Head and Neck Cancer Genomics 
  Eilat, Israel - 1/2/2017
• Oral Cavity Cancer (Instructional Course) 
  Eilat, Israel - 1/1/2017
• Current Standards and new perspectives on the treatment of Oral Cancer 
  Albert Einstein College of Medicine, Bronx, NY - 1/21/2016
• Rugged Individualism versus The Collective Good 
  Albert Einstein College of Medicine, Bronx, NY - 1/21/2016
• Current Management of Oral Cavity Cancer 
  Seattle, WA - 1/19/2016
• Head and Neck Genomics: Where Do We Go From Here? 
  Dubai, United Arab Emirates - 1/15/2016
• Current Standards and New Perspectives on Treatment of Oral Cancer 
  Schulich Medicine & Dentistry - Western University, London, Ontario, Canada, 2015; UCLA, Los Angeles - 1/11/2016
• Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions 
  Medical University of South Carolina, Charleston, SC - 1/11/2016
• Personalization of Head and Neck Cancer Therapy 
  Medical University of South Carolina, Charleston, SC - 1/11/2016
• What is the role of TORS in the Treatment of Oropharyngeal Cancer 
  Heliopolis, Cairo, Egypt - 1/6/2016
• Understanding the Causes and Impact of Extra-Nodal Spread in Oral Cancer 
  Taoyuan, Taiwan - 1/5/2016
• Leveraging Genomics to Improve Outcomes for Patients with Oral Squamous Cell Carcinoma 
  University of Michigan, School of Dentistry, Ann Arbor, MI - 1/5/2015
• Head and Neck Cancer Genomics: Where do we go from here? 
  Multiple Dates and Locations - 1/1/2015
• Technical and Anatomic Considerations for Sentinel Lymph Node Biopsy for Head and Neck Cancers 
  University of Texas School of Dentistry, Houston, TX - 1/1/2015
• Head and Neck Oncology in Wine Country: Multi-disciplinary Approach and Tumor Boards 
  Napa, CA - 1/1/2014
• Join now to see all